Literature DB >> 1991900

Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.

M Nobuyoshi1, T Kimura, H Ohishi, H Horiuchi, H Nosaka, N Hamasaki, H Yokoi, K Kim.   

Abstract

Histopathologic examination was performed in 20 patients undergoing antemortem coronary angioplasty. Thirty-four lesions were dilated and the interval between coronary angioplasty and death ranged from several hours to 4 years. Intimal proliferation of smooth muscle cells, as a major cause of restenosis, was observed in 83% to 100% of 28 lesions examined 11 days to 2 years after coronary angioplasty. In 20 lesions examined within 6 months, proliferating smooth muscle cells were predominantly of the synthetic type and there was abundant extracellular matrix substance chiefly composed of proteoglycans. In eight lesions examined between 6 months and 2 years, contractile type smooth muscle cells were dominant and extracellular matrix was composed chiefly of collagen. In three lesions examined after 2 years, evidence of antemortem coronary angioplasty was hardly identifiable and these lesions were almost indistinguishable from conventional atherosclerotic plaque. These temporal changes in histologic pattern provide a pathologic background for clinical reports that restenosis is predominantly found within 6 months after coronary angioplasty. Morphometric analysis revealed that the extent of intimal proliferation was significantly greater in lesions with evidence of medial or adventitial tears than in lesions with no or only intimal tears.

Entities:  

Mesh:

Year:  1991        PMID: 1991900     DOI: 10.1016/s0735-1097(10)80111-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  38 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Mechanisms of myocardial hypoperfusion during rotational atherectomy of de novo coronary artery lesions and stenosed coronary stents: insights from serial myocardial scintigraphy.

Authors:  Karl-Christian Koch; Peter W Radke; Eduard Kleinhans; Susanne Ninnemann; Uwe Janssens; Heinrich G Klues; Udalrich Buell; Peter Hanrath; Juergen vom Dahl
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

3.  Function and structure of pressurized and perfused porcine carotid arteries: effects of in vitro balloon angioplasty.

Authors:  Jop Perrée; Ton G van Leeuwen; Raphaella Kerindongo; Jos A E Spaan; Ed VanBavel
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

4.  Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography.

Authors:  P W Serruys; D P Foley; P J de Feyter
Journal:  Br Heart J       Date:  1992-10

5.  Serial six year quantitative angiographic follow up in asymptomatic patients following successful coronary angioplasty.

Authors:  Y Takeda; T Kobayashi; N Awata; S Sato; J H C Reiber; T Nakagawa; E Tsuchikane; O Katoh; M Kirino; T Kobayashi; K Yachiku; N Shibata
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

Review 6.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

Review 7.  Recent advances in cardiology.

Authors:  C F Shakespeare; D J Coltart
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

Review 8.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 9.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

10.  Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings.

Authors:  Brian C Tse; Jena J Steinle; Dianna Johnson; Barrett G Haik; Matthew W Wilson
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.